Patents by Inventor Erwin Soutscheck
Erwin Soutscheck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20090098528Abstract: The present invention concerns a polypeptide which is composed of the amino acids 1207±10 to 1488±10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.Type: ApplicationFiled: October 11, 2007Publication date: April 16, 2009Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Urban Schmitt, Manfred Motz, Michael Wiedmann, Barbara Upmeier, Erwin Soutscheck
-
Patent number: 7083792Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.Type: GrantFiled: January 22, 2004Date of Patent: August 1, 2006Assignee: Mikrogen Molekularbiologische Entwicklungs - GmbHInventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
-
Publication number: 20040253611Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.Type: ApplicationFiled: January 22, 2004Publication date: December 16, 2004Applicant: Mikrogen Molekularbiologische Entwicklungs-GmbHInventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
-
Patent number: 6753183Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.Type: GrantFiled: November 7, 2002Date of Patent: June 22, 2004Assignee: Mikrogen Molekularbiologische Entwicklungs-GmbHInventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
-
Publication number: 20030157562Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.Type: ApplicationFiled: November 7, 2002Publication date: August 21, 2003Applicant: Mikrogen Molekularbiologische Entwicklungs-GmbHInventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
-
Patent number: 6509019Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.Type: GrantFiled: November 13, 2000Date of Patent: January 21, 2003Assignee: Mikrogen Molekularbiologische Entwicklungs-GmbHInventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
-
Patent number: 6248538Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.Type: GrantFiled: March 10, 1994Date of Patent: June 19, 2001Assignee: Mikrogen Molekularbiogische Entwicklungs - GmbHInventors: Manfred Motz, Erwin Soutscheck, Renate Fuchs, Bettina Wilske, Vera Preac-Mursic
-
Patent number: 6183755Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.Type: GrantFiled: November 19, 1998Date of Patent: February 6, 2001Assignee: Mikrogen Molekularbiologische Entwicklungs- GmbHInventors: Manfred Motz, Erwin Soutscheck, Renate Fuchs, Bettina Wilske, Vera Preac-Mursic